Personalised medicine for multiple sclerosis care
نویسندگان
چکیده
منابع مشابه
Personalised Medicine
In recent years we have seen the emergence of “personalised medicine.” This development can be seen as the logical product of reductionism in medical science in which disease is increasingly understood in molecular terms. Personalised medicine has flourished as a consequence of the application of neoliberal principles to health care, whereby a commercial and social need for personalised medicin...
متن کاملP57: Herbal and Complementary Medicine for the Treatment of Multiple Sclerosis
Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Signs and symptoms of MS vary widely and depend on the amount of nerve damage and which nerves are affected. A literature search was conducted using medical and health science electronic databases (PubMed and SID) up to January 31, 2018. Of the 150 records identified, 25 articles were eligible a...
متن کاملThe potential and limitations of personalised medicine in primary care.
been developed for screening and for clinical prediction leaves open a temptation to confuse the two, and to misapply them in circumstances for which they were not designed. Tools designed to be used for screening are not necessarily effective in cases of individual decision making. This is not to say that there can never be circumstances in which screening tools are appropriate for individual ...
متن کاملThe future of technologies for personalised medicine.
Personalised medicine promises prediction, prevention and treatment of illness that is targeted to individuals’ needs. New technologies for detailed biological profiling of individuals at the molecular level have been crucial in initiating the move to personalised medicine; further novel technologies will be necessary if the vision is to become a reality. We will need to develop new technologie...
متن کاملComplementary and alternative medicine and multiple sclerosis.
Complementary and alternative medicine (CAM) is used by one-half to three-fourths of multiple sclerosis (MS) patients. Although it is used widely, CAM may not be discussed during a conventional medical visit. In MS, CAM therapies exhibit a broad range of risk-benefit profiles; some of these therapies are low risk and possibly beneficial, whereas others are ineffective, dangerous, or unstudied. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Multiple Sclerosis Journal
سال: 2016
ISSN: 1352-4585,1477-0970
DOI: 10.1177/1352458516672017